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Qualitative and quantitative analyses of protein phosphorylation
in naive and stimulated mouse synaptosomal preparations
Abstract
Activity-dependent protein phosphorylation is a highly dynamic yet tightly regulated process essential
for cellular signaling. Although recognized as critical for neuronal functions, the extent and
stoichiometry of phosphorylation in brain cells remain undetermined. In this study, we resolved
activity-dependent changes in phosphorylation stoichiometry at specific sites in distinct subcellular
compartments of brain cells. Following highly sensitive phosphopeptide enrichment using immobilized
metal affinity chromatography and mass spectrometry, we isolated and identified 974 unique
phosphorylation sites on 499 proteins, many of which are novel. To further explore the significance of
specific phosphorylation sites, we used isobaric peptide labels and determined the absolute quantity of
both phosphorylated and non-phosphorylated peptides of candidate phosphoproteins and estimated
phosphorylation stoichiometry. The analyses of phosphorylation dynamics using differentially
stimulated synaptic terminal preparations revealed activity-dependent changes in phosphorylation
stoichiometry of target proteins. Using this method, we were able to differentiate between distinct
isoforms of Ca2+/calmodulin-dependent protein kinase (CaMKII) and identify a novel activity-regulated
phosphorylation site on the glutamate receptor subunit GluR1. Together these data illustrate that mass
spectrometry-based methods can be used to determine activity-dependent changes in phosphorylation
stoichiometry on candidate phosphopeptides following large scale phosphoproteome analysis of brain
tissue.
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SUMMARY 
Activity-dependent protein phosphorylation is a highly dynamic yet tightly regulated process 
essential for cellular signaling. Although recognized as critical for neuronal functions, the 
extent and stoichiometry of phosphorylation in brain cells remain undetermined. In this 
study, we resolved activity-dependent changes in phosphorylation stoichiometry at specific 
sites in distinct sub-cellular compartments of brain cells. Following highly sensitive 
phosphopeptide enrichment using immobilized metal affinity chromatography and mass 
spectrometry, we isolated and identified 974 unique phosphorylation sites on 499 proteins, 
many of which are novel. To further explore the significance of specific phosphorylation 
sites, we used isobaric peptide labels and determined the absolute quantity of both 
phosphorylated and non-phosphorylated peptides of candidate phosphoproteins and estimated 
phosphorylation stoichiometry. The analyses of phosphorylation dynamics using 
differentially stimulated synaptic terminal preparations revealed activity-dependent changes 
in phosphorylation stoichiometry of target proteins. Using this method, we were able to 
differentiate between distinct isoforms of Ca2+/calmodulin-dependent protein kinase 
(CaMKII) and identify a novel activity-regulated phosphorylation site on the glutamate 
receptor subunit GluR1. Together, these data illustrate that mass spectrometry-based methods 
can be used to determine activity-dependent changes in phosphorylation stoichiometry on 
candidate phosphopeptides following large-scale phosphoproteome analysis of brain tissue. 
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INTRODUCTION 
Activity-dependent protein phosphorylation is one of the most ubiquitous and vital 
biochemical processes that contributes to the regulation and fine-tuning of numerous cellular 
functions in many cell types. At the molecular level, the addition or removal of a phosphate 
residue can considerably affect the function and/or localization of proteins including 
enzymes, ion channels, scaffolding proteins or signaling molecules. In the nervous system, 
many proteins are known to be phosphorylated in an activity-dependent fashion in discrete 
cellular compartments. In synaptic terminals, phosphorylation of pre- and post-synaptic 
proteins is required for basal neurotransmission and synaptic plasticity at both excitatory and 
inhibitory connections. Multiple protein kinases and phosphatases are necessary for the 
induction and maintenance of major forms of synaptic plasticity such as long-term 
potentiation (LTP), long-term depression (LTD) or depotentiation (1), and for cognitive 
functions (2, 3). For instance, phosphorylation can modulate the activity 
(autophosphorylation at Thr286) and translocation (Thr305/306) of CaMKIIα (4), or channel 
conductivity (Ser831, Ser845 for GluR1) (5). Evidence from functional studies underlines the 
broad requirement for phosphorylation and the existence of many critical targets in nerve 
cells. For example, tyrosine phosphorylation is important for NMDA receptor gating, 
although it is unclear how many of the 25 or more tyrosine residues on the NR2A and NR2B 
C-termini play specific biological roles (6). The identification of such targets and their 
phosphorylation sites is clearly a pre-requisite for a full understanding of the molecular 
mechanisms of brain functions.  
 
Recent advances in proteomics have allowed large-scale analysis of phosphopeptides from 
proteolytic digests of complex samples (7, 8). However, a major limiting factor in these 
analyses is the restricted selectivity and coverage of phosphopeptides, partly due to inherent 
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 4 
unsuitability of standard peptide separation and detection techniques to short, hydrophilic, 
and negatively charged peptides. Notwithstanding, interesting data was obtained from the 
combination of ion exchange fractionation of proteolytic digests and immobilized metal 
affinity chromatography (IMAC) of phosphopeptides (9-11). But although several studies 
have examined sub-cellular neural phosphoproteomes (11-16) the dynamics and 
stoichiometry of protein phosphorylation in the brain remains unstudied.   
 
Here, we describe a comprehensive workflow that allows the identification of biologically 
important phosphorylation sites from large phosphoproteomic data sets in the adult mouse 
brain. Using a highly sensitive, selective and reproducible phosphopeptide enrichment 
method based on strong-cation exchange chromatography (SCX) and IMAC, we identified a 
multiple candidate phosphorylation sites in proteolytic digests of synaptic membranes, post-
synaptic densities (PSD) and synaptic vesicles. The use of synthetic peptides and isobaric 
peptide tags allowed us to determine the relative and absolute abundance of selected 
phosphopeptides and ultimately estimate activity-dependent changes in phosphorylation 
stoichiometry in stimulated synaptosomal preparations. The workflow has the potential to 
rapidly single out phosphorylation sites likely to be regulated by neural activity, and adds a 
new dimension to the analyses of protein phosphorylation in complex tissue such as the brain. 
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RESULTS 
Streamlined high-throughput identification of phosphorylation sites 
Peptides from proteolytic digests of synaptic membranes, PSD or synaptic vesicles were first 
fractionated by charge using SCX, then subjected to a second phosphopeptide-specific 
enrichment using IMAC. Phosphopeptide-enriched samples were further fractionated by 
reverse-phase chromatography and analyzed by mass spectrometry (LC-MS/MS) using either 
electrospray ionization  (ESI-MS/MS) or matrix-assisted laser/desorption ionization 
(MALDI-MS/MS). Following the analysis of 17570 MS/MS spectra, we identified 6743 
phosphorylated peptide sequences corresponding to 974 unique phosphorylation sites on 499 
proteins (see Supplementary Tables 1 and 2 online). The specificity of enrichment was 
extremely high, with most samples consisting primarily of phosphopeptides (see 
Supplementary Figure 1 online). Phosphorylation was observed on serine, threonine and 
tyrosine residues according to expected ratios (77% Ser, 21% Thr, 2% Tyr) with a majority of 
residues being mono-phosphorylated and 0.4% bi-phosphorylated (no tri- or more 
phosphorylated sites identified with confidence). Increased coverage of phosphosites was 
achieved by using complementary proteolytic enzyme endoproteinase Glu-C (instead of 
trypsin), and other mass spectrometers. In particular, nano-flow LC coupled to MALDI-
MS/MS yielded high quality data even though phosphopeptide ionization efficiency is low 
using this method. In our hands, the quality and quantity of data from SCX-IMAC workflow 
were superior to analysis of SCX fractions without phosphopeptide enrichment. Following 
identification analyses, we investigated the functional significance of collected 
phosphoproteins and performed hierarchical cluster analysis of annotated gene ontologies 
from the gene ontology consortium (17). These analyses revealed a high diversity and broad 
coverage of the collection and provided significant functional representations in different 
sub-fractions (Figure 1a, b). In the PSD for instance, (Figure 1a) significant representation of 
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 6 
gene ontologies included molecular functions (i.e. CaMKII activity; GO:0004685; 
p=0.0096), biological process (i.e. regulation of synaptic plasticity; GO:0048167; p=0.0242) 
or cellular component (i.e. extra-cellular matrix; GO:0031012; p=0.0132). In synaptic 
vesicles (Figure 1b), significantly represented ontologies were dominated by categories 
related to microtubule and cytoskeletal proteins, consistent with the large number of 
sequenced phosphopeptides (italicized in parentheses) for microtubule-associated proteins 
MAP1A (25), MAP1B (162), MAP2 (61), MAP4 (13) or MAPT (Tau) (45). Ontologies 
including molecular function such as synaptic vesicle exocytosis (GO:0016079; p=0.0292) or 
vesicle-mediated transport (GO:0016192; p=0.0306) were also significantly represented.  
 
Quality control was performed by analysis of synthetic phosphopeptides corresponding to 
those identified in phosphoproteome dataset acquisition. A comparison between MS/MS 
spectra of corresponding synthetic phosphopeptides and experimentally observed 
phosphopeptides from biological samples resulted in a perfect match, strongly supporting the 
deduced identity (see Supplementary Figure 2 online). A large proportion of identified 
phosphopeptides was novel, many of which revealed on prominent synaptic proteins. For 
instance, a total of 21 sites were newly identified on glutamate receptor NMDA (NR2), disks 
large-associated protein (DAP), protein kinase C (PKC) and CaMKII (Table 1). Wherever a 
distinction was possible, identified phosphorylation sites were found in defined or predicted 
intracellular domains. Together, this data demonstrates the efficiency and specificity of the 
method, and the quality of the collected data.  
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Relative quantification of proteins using isobaric peptide tags 
The recent introduction of isobaric peptide tags for relative and absolute quantification 
(iTRAQ) of proteins in different samples represents a major breakthrough in quantitative 
proteomics (18). iTRAQ is based on the differential covalent labeling of peptides from 
proteolytic digests with one of four iTRAQ reagents resulting in the incorporation of 144.1 
Da to peptide N-termini and lysine residues. Peptides with different tags are indistinguishable 
by mass but can be differentiated by collision-induced dissociation (CID) (normally applied 
during MS peptide sequencing) through release of a reporter ion, each of which with a 
different mass (114.1, 115.1, 116.1 or 117.1 Da). The analysis of the intensity of reporter ions 
allows the simultaneous sequencing and quantification of labeled peptides. We first evaluated 
the effectiveness and reproducibility of iTRAQ labeling on our protein extracts. Sample 
digestion followed by iTRAQ labeling showed that the method is efficient and reproducible 
(see Supplementary Figure 3 online). iTRAQ labeling was used to examine the reliability of 
our sub-cellular fractionation protocol. Digests of synaptic membranes, PSDs and synaptic 
vesicles were differentially labeled with three iTRAQ reagents (114, 115 and 116 
respectively) then fractionated by SCX, and the relative abundance of proteins was 
determined and compared in each preparation. The results revealed that each fraction carried 
a specific pool of proteins. PSD preparations were enriched 1.5-fold with 49 specific proteins 
including glutamate receptors, scaffolding proteins, kinases and transport proteins (see 
Supplementary Figure 4a online). Likewise, synaptic vesicles preparations were highly 
enriched in several classes of vesicular components such as vesicle proteins, proton pumps 
and proteins involved in lipid metabolism (see Supplementary Figure 4b online). Notably, 
this latter fraction contained a higher proportion of specific proteins when compared to 
synaptic membranes or PSD preparations. For example, the clathrin-coated vesicle proton 
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 8 
pump (ATP6v0a1) identified from the 1460.8 Da peptide D39LNPDVNVFQR49 was enriched 
by 7-fold in synaptic vesicle preparations (Figure 2). 
 
Relative quantification of activity-dependent changes in specific peptides 
Evaluating the relative amount and activity-dependent changes of specific peptides in 
complex samples is an important step in the understanding of biological functions. Efficient 
measurement of changes in the level of specific peptide sequences can be performed by using 
inclusion lists that target desired peptide masses. Such inclusion list can also help resolve 
subtle sequence differences between isoforms and allow the quantification of these isoforms. 
Exploiting the multiplexing possibilities of iTRAQ reagents, we labeled peptides from PSD 
digests in control and KCl-stimulated synaptosome preparations and targeted several peptides 
including peptides specific for CaMKIIα and CaMKIIβ isoforms for fragmentation. We used 
the tryptic peptides Q284ETVDCLK291 and Q285ETVECLK292 that differ by a single amino 
acid substitution (D→E) in position 5 and are selective for autophosphorylated forms of 
respectively, CaMKIIα or CaMKIIβ (19). Isolated synaptosomes can function as 
physiologically-independent units containing the necessary machinery for a wide range of 
cellular mechanisms including protein translation and synaptic signaling and therefore, can 
be used reliably to examine activity-dependent processes (20). Figure 3a shows a precursor 
ion scan containing both Q284ETVDCLK291 and Q285ETVECLK292 peptides m/z 1108.6 and 
1122.6 and Figure 3b shows the resultant MS/MS for Q285ETVECLK292, with released 
iTRAQ reporter ions. Figure 3c shows the quantification of relative changes in the 
abundance of several specific tryptic CaMKII peptides from different isoforms. Examination 
of the relative amount of specific peptides relating to phosphorylated and non-phosphorylated 
sequences reveals changes in phosphoproteins under different experimental conditions. In 
KCl-stimulated synaptosomes, the amount of phosphorylated CaMKIIα and CaMKIIβ was 
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 9 
significantly increased as shown by increased relative amount of Q284EpTVDCLK291 and 
Q285EpTVECLK292 peptides (p<0.05). Consistently, the amount of the corresponding non-
phosphorylated peptides Q284ETVDCLK291 and Q285ETVECLK292 simultaneously decreased. 
Additionally, examination of isoform specific peptides I434TQYLDAGGIPR445 and 
F461YFENLLAK469 indicated no significant change in the total amount of protein. These data 
illustrate that a careful peptide selection can reveal the behavior of specific modifications on 
distinct protein isoforms. 
  
Absolute quantification of synaptic phosphoprotein stoichiometry 
An additional major advantage of multiplex iTRAQ labeling is the possibility to determine 
the molar amount of peptides from sample digests and the amount of protein by including a 
defined quantity of synthetic peptides labeled with one of the reagents. Initial investigations 
were conducted to assess the precision of absolute quantification of selected peptides from 
PSD digests. The results indicated that iTRAQ labeling is precise (less than 7% error) and 
allowed the determination of the abundance of important synaptic proteins such as CaMKII 
and glutamate receptors (see Supplementary Figure 5 online). We then performed absolute 
quantification of phosphorylated and non-phosphorylated isoform-specific GluR1 peptides. 
We labeled corresponding synthetic tryptic peptides with iTRAQ117 and combined them 
with peptides from stimulated synaptosomes labeled with iTRAQ114-116. Internal standards 
not only allow the determination of exact molar quantity of peptides in biological samples 
labeled with iTRAQ114-116 (absolute quantification), but also improve the detection of 
phosphorylation sites present in low abundance and/or stoichiometry by raising the intensity 
of ionized peptide ions above the detection threshold. Consequently, absolute quantification 
of both phosphorylated and non-phosphorylated peptides coming from a defined protein can 
be used to estimate the phosphorylation stoichiometry of a given site. Using this approach, 
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we determined the phosphorylation stoichiometry of several synaptic proteins and found a 
large range of stoichiometry values (see Supplementary Figure 6 online). One 
phosphopeptide frequently observed in our phosphoproteome screens was 
pS691PSAEAAAPPPGPR704 from G protein-regulated inducer of neurite outgrowth 1 
(Gprin1). Analysis of the ratio of the synthetic phosphopeptide to the amount of 
phosphorylated (pS691PSAEAAAPPPGPR704) and non-phosphorylated peptide 
(S691PSAEAAAPPPGPR704) estimated 91% phosphorylation stoichiometry (6.0 pmol 
phosphorylated, 0.6 pmol non-phosphorylated). Conversely, CaMKII and GluR1, known to 
be phosphorylated during excitatory neuronal signaling, had phosphorylation stoichiometry 
of up to 50%. 
 
To further investigate phosphorylation stoichiometry, we determined the absolute quantity of 
non-phosphorylated versus phosphorylated GluR1 in control and KCl-stimulated conditions. 
Figure 4a, b show the precursor ion and MS/MS scans of the iTRAQ-labeled GluR1 
phosphopeptide T856SpTLPR861 at a mass of 898.3 Da. Absolute quantification of 
T856SpTLPR861 (2.6 pmol/100 µg PSD) and a corresponding non-phosphorylated GluR1 
specific peptide Y714AYLLESTMNEYIEQR729 (14 pmol/100 µg PSD) allowed calculation of 
basal phosphorylation stoichiometry of 19%. After KCl stimulation, the phosphorylation 
stoichiometry of GluR1 at T858 increased to 28% (Figure 4c). Activity-dependent increases 
in phosphorylation stoichiometry were also observed for CaMKIIα and CaMKIIβ isoforms 
(Figure 4c). Changes in CaMKIIβ phosphorylation stoichiometry were measured by 
quantification of the peptides Q285EpTVECLK292 and F461YFENLLAK469 for phosphorylated 
and total CaMKIIβ respectively, before and after KCl stimulation. Under basal conditions, 
the peptides were present at 1.4 pmol and 29 pmol/100 µg PSD respectively, indicating 5% 
phosphorylation stoichiometry. After KCl stimulation, this ratio significantly increased to 
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15%, indicating increased CaMKIIβ phosphorylation with little increase in absolute protein 
level. A parallel increase in phosphorylation stoichiometry of CaMKIIα isoforms was 
demonstrated by determining the absolute quantity of the isoform specific peptides 
Q284EpTVDCLK291 and I434TQYLDAGGIPR445.  
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DISCUSSION 
A combined strategy for the identification, absolute and relative quantification of 
phosphoproteins in synaptic terminals 
This study describes a workflow to examine activity-dependent changes in phosphorylation 
level and stoichiometry of candidate sites identified by high-throughput post-translational 
modification analysis on proteins from adult brain. In this multi-approach strategy, each step 
was optimized to enhance coverage and specificity of phosphoproteomic datasets originating 
from complex tissue. Optimal protocols were developed for efficient sub-cellular 
fractionation of synaptic terminals, sample digestion with complementary proteases, 
purification and enrichment of phosphopeptides, and a range of mass spectrometers (MS) was 
used. One of the key steps was the development of a protocol for phosphopeptide enrichment 
with high sensitivity and selectivity that allowed the generation of large phosphopeptide 
datasets. The low abundance of non-phosphorylated peptides in our samples avoided the 
usual bias during MS/MS fragmentation and considerably increased the quality and reliability 
of phosphopeptide identification. 
 
The described analysis of the phosphoproteome in different synaptic terminal preparations 
from the adult mouse brain extends previous proteomic studies in the nervous system. For 
example, recent proteomic analyses have described proteins and phosphoproteins in 
synaptosomes from cerebellar neurons and astrocytes, or the PSD (11, 14, 21-24). The 
emphasis of these studies was primarily on the identification of phosphoproteins in basal 
conditions rather than on the analysis of changes in phosphorylation, and their biological 
significance. Our identification of novel phosphorylation sites on a large number of synaptic 
proteins and of activity-dependent changes of some sites provides a major step towards a 
better understanding of protein functions. It also underscores the extent and dynamics of 
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protein phosphorylation in the adult brain and demonstrates that it is possible to generate 
functional read-outs of protein phosphorylation using proteomics methodologies.  
 
Activity-dependent phosphorylation of specific synaptic proteins 
Applying these methodologies to investigate uncharacterized phosphorylation sites provided 
novel interesting findings about specific phosphoproteins. For instance, the novel 
phosphorylation site revealed on GluR1 T858 was found to lie between two well-known sites 
at S849 and S863 (referred to as S831 and S845 in the literature) known to be important for 
several forms of synaptic plasticity, and in learning and memory (5). The presence of a third, 
activity-regulated phosphorylation site on the C-terminus of GluR1 provides a potential 
complementary site for the mechanisms of regulation of the receptor. The extent and 
specificity of functional modulation of GluR1 by phosphorylation is likely to depend on the 
extent of phosphorylation of each of the sites implying a “phosphorylation code”. Other 
studies have suggested that clusters of post-translational modifications on intracellular 
regions of membrane proteins have functional significance (25). Such clusters of 
phosphorylation sites are thought to exist on many synaptic proteins, creating negatively 
charged pockets important to modulate or maintain specific functions. This was previously 
demonstrated for the membrane protein stargazin involved in glutamate receptor trafficking. 
Stargazin was reported to carry multiple phosphorylation sites that alter the electrostatic 
properties of the protein tail and increase its mobility and recruitment to the PSD (25). The 
variable level of phosphorylation was postulated to be the result of graded level of kinase and 
phosphatase activity. This graded multiplicity could produce further fine-tuning of 
information processing and storage in synapses. Our phosphoproteomic screens reveal many 
novel phosphorylation sites in close proximity to previously characterized ones, supporting 
this possibility.  
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Advantages of isobaric peptide tags for absolute quantification 
The major advantages and power of this workflow are illustrated by the determination of 
CaMKII phosphorylation stoichiometry. Excitatory synaptic signaling is known to facilitate 
CaMKII phosphorylation resulting in the activation of major forms of synaptic plasticity such 
as LTP, and favoring learning and memory processes (4). Two major isoforms of CaMKII, 
CaMKIIα and CaMKIIβ, exist in mammalian synapses and are both phosphorylated at 
homologous positions at Thr286 and Thr287 respectively. This degree of similarity makes it 
difficult to discriminate between the two isoforms by classical approaches. This was however 
easily achieved using MS-based methods using the fact that corresponding tryptic peptides 
differ by a single amino acid substitution.  
 
Another advantage of the method is that the inclusion of synthetic peptide spikes increases 
the limit of detection of phosphopeptides, in particular low abundance phosphopeptides that 
are difficult to analyze in complex samples without enrichment. It also offers the option to 
analyze peptides from smaller samples such as sub-cellular fractions from selected brain 
regions. The simultaneous analysis of synthetic and biological peptides can also provide an 
additional useful means to confirm the existence of putative phosphorylation sites from large 
phosphoproteome screens, as database searches alone are often not sufficient to confidently 
assign both peptide sequence and modification position. Finally, multiplex analysis with 
isobaric iTRAQ reagents allows the analysis of up to four samples, and the simultaneous 
determination of phosphorylation stoichiometry under three different experimental 
conditions.  
 
Biological significance of phosphorylation stoichiometry 
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The biological significance of synaptic protein phosphorylation stoichiometry has not been 
well addressed up to now because most biochemical experiments to date have examined 
relative but not absolute changes in phosphorylation under different experimental conditions. 
The present study investigated both relative and absolute changes in phosphorylation 
stoichiometry of several prominent synaptic proteins under basal conditions and after KCl 
stimulation. These analyses revealed that phosphorylation stoichiometry varies significantly 
between phosphosites and proteins. For instance, 5 and 50% of CaMKII and GluR1 were 
estimated to be phosphorylated under resting conditions, but about 91% of Gprin1. The 
precise biological importance of such phosphorylation stoichiometry is not known. Low 
stoichiometry in basal conditions is likely to provide a larger window for the action of protein 
kinases and a broader possibly faster, dynamic range for protein activation or inhibition 
during cell signaling. High stoichiometry in contrast may allow more stable, less dynamic 
and transient functions such as stabilization of quaternary structure at the plasma membrane, 
or maintenance of homeostatic processes. Future experiments based on the methodology 
described in this paper intend to investigate the functions of novel phosphorylation sites. 
Additional refinement of experimental protocols should allow for example, the analysis of 
specific kinases and phosphatases, or pathways stimulated by drug application. 
 
Conclusion 
Together, this data demonstrates that MS-based proteomic techniques can be used to examine 
functional aspects of protein phosphorylation in complex tissue such as brain. A small screen 
of selected phosphorylation sites in defined experimental conditions can help identify 
candidate phosphorylation sites for downstream analysis. As shown with the novel GluR1 
phosphorylation site, the identification of sites modulated by activity provides valuable 
candidates for subsequent studies investigating the function of phosphorylation. Establishing 
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the ratio of phosphorylated to non-phosphorylated peptides in different experimental 
conditions using absolute quantification should be useful to studies on synaptic signaling 
using mathematical models based on interaction networks. Such approaches have the 
potential to further exploit MS-based techniques to produce functional data, and broaden the 
understanding of post-translational protein modifications. 
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EXPERIMENTAL PROCEDURES 
Sample preparation 
Sub-cellular fractionation of mouse cortex was performed as previously described (26). 
C57/B6 mice (2-5 months old) were sacrificed by cervical dislocation and the cortex was 
rapidly removed and washed in ice cold Buffer A (0.32 M sucrose, 4 mM HEPES, pH 7.4 
with the addition of protease cocktail inhibitor tablets (Roche) and phosphatase inhibitor 
cocktail I and II (Sigma)). Cortices were homogenized in 10 volumes Buffer A by 12 to 15 
up-and-down strokes of the homogenizer. The resulting homogenate was centrifuged at 1000 
g for 10 minutes to remove nuclei and cell debris and supernatant was collected. The pellet 
was washed again at 1000 g and the supernatant S1 combined. The S1 fraction was 
centrifuged at 17 000 g to give pellet P2 which was washed to give a crude membrane 
fraction which contains intact synaptosomes. Synaptosomes were lysed by hypotonic shock 
in 9 volumes H2O before addition of HEPES to 4 mM and 30 minute incubation on ice 
shaking and centrifuged at 25 000 g to yield pelleted membranes and supernatant S3. The 
resulting synaptic membranes were made to 0.32 M sucrose and layered over a 0.8 M sucrose 
solution and centrifuged for 20 minutes at 230 000 g to separate synaptic membranes and 
mitochondria from myelin. The pellet containing synaptic and mitochondrial membranes was 
re-suspended in 0.32 M sucrose and layered over a 1.2 M sucrose solution and centrifuged for 
20 minutes at 230 000 g to pellet synaptic membranes. Synaptic vesicles were prepared by 
pelleting S3 fractions at 165 000 g for 2 hours. Crude PSD fractions were prepared by their 
insoluble properties in 0.5% Triton X-100. Pelleted fractions were frozen at -80 °C until 
analysis. 
 
KCl-stimulation of synaptosomes 
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Synaptosomes were enriched as described above, re-suspended in Krebs Ringer solution and 
incubated for 20 minutes at 37 °C. Samples were stimulated by the addition of KCl to give 50 
mM and incubated for a further 2 minutes at 37 °C. The reactions were terminated by the 
addition of ice cold buffer containing kinase and phosphatase inhibitors before further 
enrichment of PSDs and synaptic vesicles as described above. 
 
In-solution digestion  
Synaptic protein fractions (0.8–2 mg for phosphopeptide enrichment; 100 µg for iTRAQ 
experiments) were desalted by acetone precipitation. For phosphopeptide enrichment 
experiments, desalted protein was solubilized in 7 M urea, 100 mM ammonium bicarbonate, 
pH 8.0, reduced with 12.5 mM DTT for 30 to 60 minutes, alkylated with 40 mM 
iodoacetamide for one hour and diluted to 1.5 M urea with 100 mM ammonium bicarbonate. 
For iTRAQ experiments, samples were solubilized and cysteine blocked according to 
manufacturer’s protocols. Samples were digested overnight with trypsin (Promega, USA) at 
37 °C (1:50 enzyme:substrate) or endoproteinase Glu-C (PrinSep, USA) at 30 °C (1:50 
enzyme:substrate).  
 
Strong-cation exchange peptide fractionation 
The peptide containing solution was acidified to pH < 3 with acetic acid, made to 25% 
acetonitrile and centrifuged at 16 000 g for 10 minutes to remove insoluble matter. Peptides 
were then loaded onto a 4.6x200 mm (phosphopeptide experiments) or 2.1x200 mm (iTRAQ 
experiments) polySULFOETHYL aspartamide A column (PolyLC, USA) on an Agilent 
HP1100 binary HPLC system. Phosphopeptide rich fractions were eluted with an increasing 
KCl gradient (0 to 105 mM over 30 minutes and 105 mM to 350 mM over the following 20 
minutes) in 10 mM KH2PO4, 25% acetonitrile, pH 3. The first five fractions were then 
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lyophilized to remove acetonitrile, desalted with Sep-Pak reverse-phase cartridges (Waters, 
UK) and lyophilized to 100 µl. For iTRAQ experiments, peptides were eluted in a two-step 
KCl gradient (0–150 mM over 30 minutes; 150–500 mM over the following 20 minutes). 
 
iTRAQ reagent labeling and absolute quantification 
Synthetic peptides (Mimotopes, Australia) were designed according to previously observed 
peptide sequences from MS analysis of synaptic terminal digests and were purified by 
reverse-phase chromatography. Lyophilized peptides were reconstituted in 1 mM stock 
solutions. To perform absolute quantification, aliquots containing 20 pmol of a library of 
peptides were prepared and stored at -80 °C. For relative or absolute quantification 
experiments, 100 µg of digested synaptic terminal protein, or known quantities of synthetic 
peptides were labeled differentially with iTRAQ reagents according to manufacturer’s 
instructions and combined before SCX fractionation and LC-MALDI analysis.  
 
Immobilized metal affinity enrichment of phosphopeptides 
IDA-coupled sepharose Fast-Flow Beads were washed with five volumes of water, five 
volumes of wash buffer (74:25:1 water:acetonitrile:acetic acid), and five volumes of 1 mM 
FeCl3 before equilibrating in five volumes of wash buffer. Peptides from SCX fractionation 
were loaded onto 75 µl of a 25% bead-slurry and incubated at room temperature for 30 
minutes. The samples were carefully washed three times with wash buffer and eluted with 
100 mM sodium phosphate buffer, pH 8.9. Samples were concentrated and desalted with 
ZipTips (Millipore, USA) before lyophilization and stored at -20 °C for analysis by mass 
spectrometry. 
 
Peptide separation, mass spectrometry and database analysis 
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Samples were re-suspended in 5% acetonitrile, 0.2% formic acid, separated onto a reverse-
phase capillary column and measured directly by nano-spray ion-trap mass spectrometry. 
Alternatively, the column effluent was directly mixed with MALDI matrix solution (5 mg/ml 
α-cyano-4-hydroxycinnamic acid in 70% acetonitrile with the addition of 1 mM ammonium 
citrate) and measured by tandem MALDI-MS. 
 
LC-ESI-MS/MS analysis using LCQ Deca 
Samples were re-suspended in 5% acetonitrile, 0.2% formic acid and loaded onto a reverse-
phase capillary column (Magic C18, 75 µm x 8 cm; 200 Å, TipiTips-ED, Switzerland) using 
a fully automated nano-flow LC-system consisting of a PAL auto sampler (CTC Analytics 
AG, Switzerland) and binary Rheos 2000 pump (Flux Instruments, Switzerland). All LC-
MS/MS runs of peptides were performed using a 160 minute binary gradient using solvent A 
(5% acetonitrile, 0.2% formic acid) and B (80% acetonitrile, 0.2% formic acid). Peptides 
were eluted with the following linear gradient: 0-3 min, 0-10% solvent B; 3-50 min, 10-50% 
solvent B; 50-60 min, 50-100% B, followed by 100% B for 5 minutes and 100% A for 22 
minutes to equilibrate. Average flow at the tip was ~0.25 µl/min after splitting. The LC 
system was directly coupled to a Thermo Finnigan LCQ Deca ion-trap mass spectrometer 
(San Jose, USA) equipped with a nano-spray ionization source. Each MS full scan was 
followed by three MS/MS spectra of the three most intense peaks. Dynamic exclusion was 
enabled using the following conditions: repeat count, 2; repeat duration, 1 min; exclusion 
duration, 4 min; exclusion mass width, 3 Da and a reject mass list with the following masses: 
304.0, 371.0, 391.0, 445.0, 1522.0, 1622.0, 1722.0, 1822.0. 
 
LC-ESI-MS/MS analysis of phosphopeptides using LTQ-FT 
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Nano LC-MS/MS of phosphopeptides was carried out on an Agilent 1100 nano HPLC 
system (Agilent Technologies, Switzerland) coupled to an LTQ-ICR-FT (Thermo Electron, 
Germany) mass spectrometer. Peptides were eluted from a home packed C18 tip column with 
an acetonitrile gradient from 3 to 60% over approximately 60 minutes. Mass accuracy (FT 
and IT) were calibrated immediately before the measurements according to manufacturer’s 
instructions. Up to 4 data-dependent tandem mass spectra were allowed, measured in the 
LTQ ion-trap. The AGC target settings for the allowed number of ions in the respective mass 
analyzers were set to 1e5 for FT full MS and 1e4 for ion-trap MS/MS scans. Dynamic 
exclusion and reject masses were employed as described above, corrected for the more 
accurate mass measurement. 
 
Nano-flow reverse-phase HPLC separation and MALDI spotting 
Peptide separation was performed on an Ultimate chromatography system equipped with a 
Probot MALDI spotting device and Famos autosampler (Dionex - LC Packings, Hercules, 
USA). 20 µl of the samples were injected and loaded directly onto a 75 µm x 150 mm 
separation  column (Inertsil ODS-3, 5 µm; Dionex - LC Packings). Peptides were eluted with 
the following gradient: 0-5 min, 0% solvent B; 5-65 min, 0-50% solvent B; 65-75 min, 50-
100% solvent B, and 75-80 min, 100% solvent B. Solvent A contained 0.1% TFA in 98:2 
water:acetonitrile, and solvent B contained 0.1% TFA in 20:80 water:acetonitrile, and the 
flow rate was 300 nl/min. For MALDI-MS/MS analysis, column effluent was directly mixed 
with MALDI matrix solution (5 mg/ml α-cyano-4-hydroxycinnamic acid in 70% acetonitrile 
with the addition of 1 mM ammonium citrate) at a flow rate of 1.1 µl/min via a µ-Tee fitting. 
Fractions were automatically deposited every 20 s onto the MALDI target plate (Applied 
Biosystems, Framingham, USA) using a Probot micro-fraction collector. For each HPLC run, 
a total of 192 spots were collected. 
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MALDI Mass spectrometry  
MALDI plates were analyzed on a 4700 Proteomics Analyser MALDI TOF/TOF system 
(Applied Biosystems). The instrument was equipped with a Nd:YAG laser operating at 200 
Hz. The mass spectra were externally calibrated using peptide standards and spectra from 192 
spots per MALDI plate were generated in positive reflector mode by accumulating data from 
1500 laser shots and then analyzed using the Peak Picker software supplied with the 
instrument. Spectral peaks that met the threshold criteria and were not on the exclusion list 
were included in the acquisition list for the MS/MS spectra. The threshold criteria were set as 
follows: mass range, 750 to 4000 Da; minimum signal-to-noise (S/N), 40; precursors/spot, 8. 
Peptide CID was performed at a collision energy of 1 keV and a collision gas pressure of 2 x 
10-7 Torr for phosphopeptide enrichment and 5 x 10-7 Torr for iTRAQ experiments. During 
MS/MS data acquisition, a method with a stop condition was used. In this method, a 
minimum of 3000 shots (60 sub-spectra accumulated from 50 laser shots each) and a 
maximum of 7500 shots (150 sub-spectra) were allowed for each spectrum. The 
accumulation of additional laser shots was halted whenever at least 4 ions with a S/N ratio of 
at least 50 were present in the accumulated MS/MS spectrum in the region from m/z 200 to 
90% of the precursor mass.  
 
Data analysis 
MS and MS/MS data were searched using Mascot version 2.1.0 (Matrix Science, London, 
UK) or Mascot version 1.9.05 (iTRAQ experiments) as the search engine (27). Database 
searching of MS/MS spectra was performed using a mouse protein database downloaded 
from the EBI (32849 sequences, 14519475 residues; release date: 25.03.2006; source: 
ftp.ebi.ac.uk/pub/databases/SPproteomes/fasta/proteomes/59.M_musculus.fasta.gz). 
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Modifications used include carbamidomethylation (C, fixed; phosphopeptide enrichment 
experiments), MMTS (C, fixed; iTRAQ experiments), oxidation (M, variable; iTRAQ 
experiments), pyro-glu (Q, variable), N-acetyl (protein, variable; MALDI only) and phospho 
(STY, variable). For ThermoFinnigan LCQ measurements, the average mass of +1, +2, and 
+3 charge peptides was searched with a peptide tolerance of 1.5 Da and MS/MS tolerance of 
0.8 Da. For ThermoFinnigan LTQ-FT measurements, the mono-isotopic mass of +1, +2, and 
+3 charge peptides was searched with a peptide tolerance of 15 ppm and MS/MS tolerance of 
0.8 Da. Searches using MALDI-MS/MS spectra were performed for mono-isotopic peptides 
with +1 charge. Error limits were set at 85 ppm for precursor masses and 0.2 Da for fragment 
ions. For data acquired from the ESI mass spectrometer mascot generic files were submitted 
to Mascot search engine using the above described search parameters. For data acquired 
using the MALDI mass spectrometer, peaks to Mascot software (Applied Biosystems; 
phosphopeptide enrichment experiments) or GPS (Global Proteome Server) Explorer 
software (Applied Biosystems; iTRAQ experiments) was used for processing spectra and 
submitting data for database searching using the search parameters described above. Positive 
identification of phosphopeptides was performed using a variety of strict criteria including 
manual inspection of spectra and Mascot expect values of less than 0.05. A normalized delta 
ions-score was calculated for all peptides by taking the difference in the ions score for the top 
two ranking peptides and dividing that difference by the first ranking peptide’s ion score (28). 
All phosphopeptides containing more than one serine, threonine or tyrosine residue, and a 
normalized delta ions-score of less than 0.4 (28) were evaluated for precise site assignment. 
The confirmation of phosphorylation sites was primarily based on the presence of site-
specific singly or doubly charged b and y type fragment ions (b and y ions generated by 
cleavages between two potential phosphorylation sites). Relative intensity of essential 
diagnostic fragment ions was checked in MS/MS spectra. Rules for increased or decreased 
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peptide cleavage probability were taken into account (enhanced cleavage on N-terminal side 
of proline and on C-terminal side of aspartic acid, reduced cleavage on C-terminal side of 
proline). Quantification of iTRAQ reporter ion intensity was performed by integrating the 
area under reporter ion peaks using Applied Biosystems 4700 Explorer software before 
combining with database search results. Only peptides with both satisfactory database 
identification and sufficiently intense iTRAQ reporter ions were selected for subsequent 
analysis. UniProt accession numbers were processed using GOMINER (29). SD, standard 
deviation of the mean; SEM, standard error of the mean. 
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Figure Legends 
 
Table 1 Overview of phosphorylated peptide sequences identified on well-characterized 
synaptic proteins. Seven sequences were identified on glutamate receptor NMDA, several of 
which not yet annotated in the databases Phosphosite (www.phosphosite.org), Phosphobase 
(www.cbs.dtu.dk/databases/PhosphoBase/) or HPRD (www.hprd.org), ten sequences were 
identified on protein kinase C (PKC). Many other characteristic PSD proteins such as 
CaMKII, PSD-95 or DAP possess multiple uncharacterized sites. A total of 21 
phosphorylation sites not annotated at the time of analysis were identified (red asterisk *). 
 
Figure 1 High-throughput identification of phosphorylation sites in synaptic terminals from 
mouse cortex. Phosphopeptides from proteolytic digests of synaptic proteins were selectively 
enriched using SCX and IMAC then analyzed by LC-MS/MS. (a, b) Hierarchical clustering 
of gene ontology with corresponding proteins significantly enriched in PSD (a) and synaptic 
vesicles (b) determined using GOMINER. Clusters of ontologies can be clearly observed for 
categories relevant to CaMKII and ionotropic glutamate receptor activity in the PSD, or 
cytoskeletal and vesicular transport proteins in synaptic vesicles. Scale indicates the number 
of phosphopeptides identified for each ontology. 
 
Figure 2 Verification of sample preparation purity using isobaric peptide tagging. Synaptic 
membranes, PSD and synaptic vesicles were prepared according to a modified procedure 
using differential centrifugation before digestion with trypsin. To reduce sample complexity, 
tryptic peptides were loaded onto an SCX cartridge and a selected population eluted with a 
single 100 mM KCl step. Synaptic membranes, PSDs and synaptic vesicles were labeled with 
114, 115, or 116 iTRAQ reagent respectively. Labeled peptides were combined and 
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fractionated by charge using SCX chromatography, before reverse-phase nano-flow 
separation onto MALDI target plates and analysis by tandem MS. (a) Precursor ion scan for 
the tryptic peptide D39LNPDVNVFQR49 from ATP6v0a1 at mass 1460.8 Da and close up 
(inset). (b) MS/MS scan of D39LNPDVNVFQR49, holding peptide fragmentation information 
data for sequencing and low mass iTRAQ reporter ion (inset) used for relative quantification 
of synaptic proteins.  
 
Figure 3 Relative quantification of CaMKIIα and CaMKIIβ peptides in PSDs after KCl 
stimulation. Tryptic digests were labeled with iTRAQ reagents (KCl-stimulated, iTRAQ114 
and 116; control iTRAQ115) and combined, then fractionated by two-dimensional liquid 
chromatography (2D-LC) and analyzed by tandem MS. (a) Precursor ion scan for the tryptic 
peptide QETVECLK from CaMKIIβ at mass 1122.6 Da and close up (inset). (b) MS/MS 
scan of QETVECLK, containing peptide fragmentation information data for sequencing and 
low mass iTRAQ reporter ion (inset) used for relative quantification of synaptic proteins. (c) 
Overview of relative quantification of CaMKII isoform-specific peptide sequences. 
Following sample standardization, significant increases were observed for the 
phosphopeptides QEpTVDCLK and QEpTVECLK in KCl-stimulated PSDs (n=2; p=0.022 
and 0.023 respectively, t-test), with no increase for peptides, ITQYLDAGGIPR and 
FYFENLLAK, specific to non-phosphorylated regions of CaMKIIα and CaMKIIβ (n=2; 
p>0.1, t-test). Consistently, a significant decrease in relative amount of non-phosphorylated 
peptide sequences QETVDCLK and QETVECLK was observed, as expected following an 
increase in phosphorylation of these residues (n=2; *p=0.026 and 0.022 respectively, t-test). 
Expressed as mean±SEM.  
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Figure 4 Absolute quantification of GluR1-specific phosphorylated and non-phosphorylated 
peptides in PSDs after KCl stimulation. Tryptic digests were labeled with iTRAQ reagents 
(control, iTRAQ114, 116; KCl-stimulated, iTRAQ115), combined with 20 pmol of 
iTRAQ117-labeled synthetic peptide, fractionated by 2D-LC and analyzed by tandem MS. 
(a) Precursor ion scan for the tryptic peptide TSpTLPR from GluR1 at mass 898.3 Da and 
close up (inset). (b) MS/MS scan of TSpTLPR, containing peptide fragmentation information 
data for sequencing and low mass iTRAQ reporter ion (inset) used for relative and absolute 
quantification. GluR1 T858 phosphorylation in PSDs from KCl-stimulated synaptosomes 
was increased by approximately 50% compared to control samples. The peak area at 117 Da 
corresponds to 20 pmol of the synthetic peptide. For clarity, the y-axis of the spectrum has 
been magnified 5-fold. (c) Activity-dependent increase in phosphorylation stoichiometry for 
CaMKIIα, CaMKIIβ and GluR1 from the PSD of stimulated synaptosomes (control: white 
boxes, stimulated synaptosomes: black boxes). Absolute quantification of complementary 
non-phosphorylated and phosphorylated peptides (as shown in Fig 3c) was used to estimate 
the upper and lower limit of phosphorylation stoichiometry. 
 
Supplementary Table 1. Phosphopeptides enriched by SCX and IMAC. Phosphorylation 
sites assigned by Mascot database search with Phospho (STY) indicated by a lower case. 
 
Supplementary Table 2. Phosphorylated proteins with their corresponding peptide/s. 
 
Supplementary Figure 1. Specificity of phosphopeptide enrichment from peptides 
fractionated by SCX. The ratio of phosphopeptides to non-phopshorylated peptides was 
extremely high for peptides from both tryptic and GluC digests. Expressed as mean±SEM. 
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Supplementary Figure 2. Use of synthetic peptides for confirmation of phosphorylation 
sites. Identical fragmentation of experimentally observed and synthetic phosphopeptides was 
used to support the existence of 30 sites. (a) The C-terminal GluR1 receptor phosphopeptide 
TSpTLPR observed in phosphopeptide enriched digests of PSD using ion-trap MS. (b) 
Synthetic phosphopeptide TSpTLPR. (c) Synthetic phosphopeptide TpSTLPR. (d) The C-
terminal NMDA receptor phosphopeptide KMPpSIESDV observed by LC-LTQ-FT analysis 
of phosphopeptide enriched digests of PSD. (e) Synthetic phosphopeptide KMPpSIESDV. 
For clarity, the y-axis of spectra 2a/b and 2c were magnified 2.5- and 10-fold respectively.  
 
Supplementary Figure 3. Verification of digestion efficiency and iTRAQ labeling. To 
verify the digestion efficiency of synaptic terminal preparations, 100 µg aliquots of synaptic 
membranes, PSD and synaptic vesicles were digested in parallel and labeled with iTRAQ 
114, 115 and 116 respectively using manufacturer’s recommended protocols and analyzed by 
2D-LC MALDI MS/MS. The relative abundance of 115-and 116-labeled peptides was 
expressed as percentage of 114-labeled peptides, with the cumulative average for the top 200 
Mascot database hits. Mean±SD is 86.5±4.4% for 115-labeled and 75.0±4.9% for 116-
labeled samples for the top 200 database hits respectively. This demonstrates the consistency 
of the ratios of 114:115:116 labeled peptides for the three digests. 
 
Supplementary Figure 4. Overview of proteins enriched in sub-cellular fractions determined 
by iTRAQ labeling. (a) Enrichment of proteins in PSD preparations included glutamate 
receptors (GRIN2B or NMDA2B), scaffolding proteins such as homer and shank, and 
kinases such as CaMKII. (b) Overview of proteins enriched in synaptic vesicle preparations. 
Over 200 proteins were enriched in synaptic vesicles, with many specific vesicle proteins 
highly represented in comparison to synaptic membrane proteins. 
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Supplementary Figure 5. Determination of the precision of iTRAQ absolute quantification. 
The precision of iTRAQ absolute quantification was determined by examining the variability 
in amount of selected peptides in biological samples processed in parallel. Three 100 µg 
samples of PSD preparations were digested and labeled with iTRAQ using the same method 
as for Supplementary Figure 3. Twenty pmol of synthetic peptide standards labeled with 
iTRAQ 117 processed in parallel to the biological samples, were used as internal standards 
following LC-MS/MS analysis. This allowed the calculation in triplicate of the absolute 
quantity of the selected peptides. Following standardization of sample amounts to eliminate 
errors in protein determination, the absolute quantity of peptides from the three PSD 
preparations was similar, with less than 7% error.  
 
Supplementary Figure 6. Estimation of phosphorylation stoichiometry in a variety of 
synaptic proteins following determination of the absolute quantity of phosphorylated and 
non-phosphorylated peptides. The range of phosphorylation stoichiometry is high, from 5% 
for CaMKIIβ to 91% for Gprin1. Expressed as mean±SD. 
 
 
 at SM
AC Consortium
 - University of Zürich on Decem
ber 18, 2009 
w
w
w
.m
cponline.org
D
ow
nloaded from
 
Table 1 Munton et al 
Protein Accession Phosphopeptide Residue Position 
CaMKIIβ KCC2B_MOUSE ESSDSTNTTIEDEDAK S* 397 
CaMKIIβ KCC2B_MOUSE NSSAITSPK S 367 
CaMKIIβ KCC2B_MOUSE QETVECLKK T 287 
CaMKIIγ KCC2G_MOUSE QETVECLR T 287 
CaMKK1 KKCC1_MOUSE SFGNPFEPQAR S 458 
CaMKK1 KKCC1_MOUSE SMSAPGSLLMK S* 475 
CaMKK2 KKCC2_MOUSE SFGNPFEGSR S* 495 
mAChR2 ACM2_MOUSE EPVANQDPVSPSLVQGR S 231 
mAChR2 ACM2_MOUSE EPVANQDPVSPSLVQGR S 233 
PSD-93 DLG2_MOUSE AISLEGEPR S 414 
PSD-93 DLG2_MOUSE QPSVTLQR S* 406 
PSD-95 DLG4_MOUSE EQLMNSSLGSGTASLR S 415 
PSD-95 DLG4_MOUSE EQLMNSSLGSGTASLR S 418 
PSD-95 DLG4_MOUSE NTYDVVYLK Y 240 
DAP-1 DLGP1_MOUSE SLDSLDPAGLLTSPK T 436 
DAP-1 DLGP1_MOUSE GCSQDDECVSLR S 509 
DAP-1 DLGP1_MOUSE ATQPSLTELTTLK S* 389 
DAP-1 DLGP1_MOUSE AVSEVSINR S* 421 
DAP-1 DLGP1_MOUSE GCSQDDECVSLR S 516 
DAP-2 DLGP2_MOUSE ADSIEIYIPEAQTR S 1047 
DAP-2 DLGP2_MOUSE SDVETATDSDTESR S* 745 
NR1 NMDZ1_MOUSE AITSTLASSFK S 890 
NR2A NMDE1_MOUSE QDSLNQNPVSQR S* 1025 
NR2A NMDE1_MOUSE GSLIVDMVSDK S* 929 
NR2A NMDE1_MOUSE KMPSIESDV S 1459 
NR2A NMDE1_MOUSE SPDFNLTGSQSNMLK T* 888 
NR2B NMDE2_MOUSE NMANLSGVNGSPQSALDFIR S* 917 
NR2B NMDE2_MOUSE QHSYDTFVDLQK S 1303 
mGluR7 MGR7_MOUSE TELCENVDPNSPAAK S* 900 
PP2Bα PP2BA_MOUSE ITSFEEAK T* 468 
PKCα KPCA_MOUSE VISPSEDR S* 318 
PKCβ KPCB_MOUSE HPPVLTPPDQEVIR T 640 
PKCε KPCE_MOUSE LAAGAESPQPASGNSPSEDDR S* 337 
PKCε KPCE_MOUSE SAPTSPCDQELK S* 350 
PKCγ KPCG_MOUSE TFCGTPDYIAPEIIAYQPYGK T* 514 
PKCγ KPCG_MOUSE MGPSSSPIPSPSPSPTDSK S* 322 
PKCγ KPCG_MOUSE SPTSPVPVPVM S* 687 
PKCγ KPCG_MOUSE TFCGTPDYIAPEIIAYQPYGK T* 518 
PKCγ KPCG_MOUSE MGPSSSPIPSPSPSPTDSK S* 330 
PKCγ KPCG_MOUSE AAPALTPPDR T 655 
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